Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Kazuko Sakai"'
Autor:
Takayuki Yoshino, Kazuko Sakai, Eiichi Morii, Takashi Kubo, Satoshi Fujii, Yae Kanai, Atsushi Ochiai, Hitoshi Ichikawa, Kazuto Nishio, Wataru Okamoto, Kanako C. Hatanaka, Yoshinao Oda, Yutaka Hatanaka, Takeshi Kuwata
Publikováno v:
Pathology International. 71:725-740
Clinical cancer genomic testing based on next-generation sequencing can help select genotype-matched therapy and provide diagnostic and prognostic information. Pathological tissue from malignant tumors obtained during routine practice are frequently
Autor:
Masayuki Takeda, Kazuto Nishio, Takayuki Takahama, Hidetoshi Hayashi, Kazuko Sakai, Takeshi Yoshida, Kazuhiko Nakagawa, Shinichiro Suzuki, Hiroyasu Kaneda, Kaoru Tanaka, Ryoji Kato, Koji Haratani, Yoshikane Nonagase, Junko Tanizaki, Kimio Yonesaka
Publikováno v:
International Journal of Clinical Oncology. 26:1628-1639
We here applied cancer personalized profiling by deep sequencing (CAPP-seq) to analysis of circulating tumor DNA (ctDNA) to identify resistance mechanisms in osimertinib-treated patients with EGFR T790M–positive non–small cell lung cancer (NSCLC)
Autor:
Kazuto Nishio, Kazuko Sakai, Yasushi Kotani, Noriomi Matsumura, Hisamitsu Takaya, Hidekatsu Nakai, Chiho Miyagawa, Akiko Kanto, Kosuke Murakami
Publikováno v:
Modern Pathology
Recent studies have reported cancer-associated mutations in normal endometrium. Mutations in eutopic endometrium may lead to endometriosis and endometriosis-associated ovarian cancer. We investigated PIK3CA mutations (PIK3CAm) for three hotspots (E54
Autor:
Hisamitsu Takaya, Noriomi Matsumura, Maho Konishi, Chiho Miyagawa, Kazuko Sakai, Toshihide Shimada, Sachiko Minamiguchi, Kazuto Nishio
Publikováno v:
Oncologist
Recently, several malignant peritoneal mesotheliomas (MPMs), occurring in young women without asbestos exposure and with fusion genes such as anaplastic lymphoma kinase (ALK) and Ewing sarcoma breakpoint region 1, have been reported. In the present c
Autor:
Masato Maekawa, Terumi Taniguchi, Kazuto Nishio, Kazuko Sakai, Kazuyuki Matsushita, Kaname Nakatani, Takayuki Ishige, Makoto Ikejiri, Hiroshi Nishihara, Kuniko Sunami, Yasushi Yatabe, Kanako C. Hatanaka, Yutaka Hatanaka, Yoshihiro Yamamoto, Keita Fukuyama, Shinya Oda, Kayoko Saito, Mamoru Yokomura, Yuji Kubo, Hiroko Sato, Yoshinori Tanaka, Misa Fuchioka, Tadashi Yamasaki, Koichiro Matsuda, Kiyotaka Kurachi, Kazuhiro Funai, Satoshi Baba, Moriya Iwaizumi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
To implement precision oncology, analytical validity as well as clinical validity and utility are important. However, proficiency testing (PT) to assess validity has not yet been systematically performed in Japan. To investigate the quality of next-g
Autor:
Shujiro Minami, Akihito Arai, Kazuto Nishio, Katsunari Yane, Hidetoshi Hayashi, Kazuko Sakai, Tomoko Yamazaki, Kaoru Tanaka, Hironobu Minami, Shigemichi Iwae, Ichiro Ota, Naoki Otsuki, Masanori Toyoda, Yoshinori Imamura, Takayuki Takahama, Ken-ichi Nibu, Yoshiaki Nagatani, Naomi Kiyota
Publikováno v:
Medical oncology (Northwood, London, England). 38(11)
The clinical utility of systemic therapy and genomic profiling in non-squamous-cell head and neck cancer (NSCHNC) has not been fully elucidated. This phase II trial evaluated the efficacy and safety of docetaxel and cisplatin combination in the first
Autor:
Atsushi Osoegawa, Tatsuma Asoh, Kosuke Kashiwabara, Taishi Harada, Takashi Miura, Kazuko Sakai, Ryotaro Morinaga, Kazuto Nishio, Takayuki Suetsugu, Masafumi Yamaguchi, Kenji Sugio, Kazuki Nabeshima, Kenichi Taguchi, Junji Kishimoto, Kentaro Tanaka, Tomomi Nakamura
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100191-(2021)
JTO Clinical and Research Reports
JTO Clinical and Research Reports
Introduction Although treatment with osimertinib confers survival benefits in patients with lung cancer with the EGFR T790M mutation, the mechanism of acquired resistance to osimertinib remains poorly understood. We conducted a prospective observatio
Autor:
Jiichiro Sasaki, Satoshi Igawa, Kazuto Nishio, Kazuhiko Nakagawa, Kazuko Sakai, Tomoya Fukui, Hisashi Mitsufuji, Katsuhiko Naoki, Mikiko Kakegawa, Takayuki Takahama, Masayuki Takeda
Publikováno v:
Cancer biomarkers : section A of Disease markers. 31(2)
BACKGROUND: The advancement of cancer genomics has allowed for multiplex gene assays using next-generation sequencing (NGS) to be practically implemented, however, a clinical practice system remains to be established. OBJECTIVE: We evaluated the feas
Autor:
Takako Inoue, Kazumi Nishino, Hanako Kuhara, Shin-ichi Nakatsuka, Fumio Imamura, Kei Kunimasa, Toru Kumagai, Motohiro Tamiya, Madoka Kimura, Kazuko Sakai, Kazuto Nishio, Harumi Nakamura
Publikováno v:
Lung Cancer. 132:59-64
Objectives SMARCA4-deficient thoracic sarcoma(DTS) is a recently identified new entity of thoracic malignancies characterized by inactivation of SMARCA4. Patients with SMARCA4-DTS have a particulary aggresive clinical course and no effective treatmen
Autor:
Toshifumi Wakai, Kentaro Yamazaki, Kentaro Sawada, Kuniko Sunami, Masayuki Takeda, Shingo Matsumoto, Yoichi Naito, Kohei Shitara, Kayo Yasuda, Takayuki Yoshino, Gen Kimura, Yasuhiro Kodera, Chikashi Ishioka, Katsuya Tsuchihara, Manabu Muto, Kumiko Umemoto, Wataru Yasui, Saori Mishima, Yumi Fujimoto, Daisuke Kotani, Kazuko Sakai, Kazuto Nishio, Shigeki Umemura, Hideaki Bando, Shigehiro Koganemaru, Hideaki Takahashi, Akihito Kawazoe, Tatsuya Suzuki, Sumito Shingaki, Noboru Yamamoto, Shota Fukuoka, Hirotoshi Dosaka-Akita, Takahiro Kogawa, Hiroshi Matsumoto, Kenichi Harano, Yoshiaki Nakamura, Yasutoshi Kuboki
Publikováno v:
Cancer Science
In Japan, the social (medical) health-care system is on the way to being developed to advance personalized medicine through the implementation of cancer genomic medicine, known as "cancer clinical sequencing," which uses a next-generation sequencer.